Middle East and Africa API Intermediate
Market Report
2024
Delivery Includes:- Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Middle East and Africa API Intermediate Market Report 2023.
According to Cognitive Market Research, the Middle East and Africa API intermediate Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Market Split by Type |
|
Market Split by Application |
|
Market Split by product |
|
Market Split by End Users |
|
Market Split by Distribution Channel |
|
List of Competitors |
|
Country Analysis | Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA | Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Middle East and Africa API Intermediate industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Middle East and Africa API Intermediate Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
According to Cognitive Market Research, the Middle East and Africa region is dominated by the countries South Arabia, South Africa, and Kuwait. With Increase in technological advancements will enhance the capabilities and boost the manufacturing skills of the market players that the manufacturers have to provide APIs in bulk and meet the demand of the consumers which can drive the growth of the Middle East and Africa active pharmaceutical ingredients (API) market
For instance- The Middle East pharmaceutical market is expected to grow around 10%-15% annually compared to less than 5% a year growth predicted in the mature markets of the US and Europe. Initiatives like offering free zones to overseas firms, including 100% ownership and tax benefits, to set up within developments such as Saudi Arabia's $534 million King Fahd Medical City in Riyadh and the Dubai Biotechnology and Research Park, are expected to fuel rapid growth in the region's overall market for biotechnology products. (source:https://tajpharma.com/tajapi/Africa%20&%20Middle%20East.htm)
Additionally, The Middle East and Africa have experienced an increase in demand for low-cost healthcare and medications. Generic pharmaceuticals, which need APIs, are frequently less expensive than branded treatments.
Read a Detailed Qualitative analysis of the above report by requesting the free sample pages from Request for your Free Sample PDF/Online Access.
The API intermediates market competitive landscape provides a detailed analysis of competitors. The detailed analysis includes company overview, company financial statements, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, company strengths and weaknesses, product launch, product width and breadth, and application dominance
Top Companies Market Share in Middle East and Africa API Intermediate Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The published report edition delivers Middle East and Africa Market size analysis from 2019 till the forecast period of 2031. We have included analysis of top performing countries such as (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA) and their Market segmentation by Type, Application, product, End Users, Distribution Channel, etc. This will help you to understand detailed segment profile, revenue generation, growth patterns, trends, and differences among the each segments.
Based on type, the bulk drug segment dominates the market of API intermediates among others. The bulk drug intermediates segment had the largest revenue share in the market. The bulk drug intermediates sector is expected to dominate the market due to the increasing prevalence of chronic disease and the development of market participants producing bulk drug intermediates. Active pharmaceutical ingredients (API) are routinely manufactured from bulk drug intermediates. The active pharmaceutical ingredient (API) is a necessary component used in the manufacture of pharmaceuticals to provide the intended therapeutic effect.
Fine chemicals, on the other hand, are produced by a limited number of companies. The developing and manufacturing process of fine chemicals is complex and usually subject to multi-step synthesis. Also They are also much more expensive to produce than bulk chemicals, due to their complexity and changing chemistries.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
Based on application, the Cardiology segment dominated the API market among other segments with a revenue share in 2023 attributable to the rising prevalence of cardiovascular diseases globally. According to the World Heart Report 2023, over half a billion people worldwide are affected by CVDs, causing approximately 20.5 million deaths in 2021 - almost a third of global deaths and an increase from the previously estimated 121 million CVD-related deaths. Cardiovascular disease is one of the world's most serious public health problems, prompting extensive research into APIs in the field.
Furthermore, the Oncology segment is anticipated to grow at the fastest growth rate over the forecast period. The increasing global prevalence of cancer is a key factor driving this market. Collaboration among pharmaceutical companies, research institutions, and regulatory entities remains pivotal in expediting drug development, ensuring patient safety, & fostering innovation.
Note: The above Chart is for representative purposes and does not depict actual sales & statistics. You can request a free sample or purchase the full report access today!
The Current Published report Editon on the website includes the following list of countries analysis whereas in case you looking to access any other country or states level data under Middle East and Africa then please revert us to access the exclusive Middle East and Africa API Intermediate industry report Edition.
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Bio :Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare indust...Read More
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Middle East and Africa API Intermediate Market is witnessing significant growth in the near future.
In 2023, the Bulk Drug Intermediates segment accounted for noticeable share of Middle East and Africa API Intermediate Market and is projected to experience significant growth in the near future.
The Oncology segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies BASF, Sanofi Winthrop and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Table of Content differs accordign to the user License selction. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section's Or chapter's from the report. Specific section's of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Type | Bulk Drug Intermediates, Chemical Intermediates |
Application | Oncology, Diabetes, Cardiovascular Disease, CNS & Neurological Disorders, Endocrinology, Other Therapeutic Applications |
product | Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1, 3-Dimethyl Uracil, Theophylline, Others |
End Users | Biotech & Pharmaceutical Companies, CMO, others |
Distribution Channel | online, offline |
List of Competitors | BASF, Jigs Chemical, Sanofi Winthrop, Ami, Cambrex, A.R.Life Sciences, Dragon Hwa, Shandong Jiulong, Hipharma, AMPAC, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla limited. |
Chapter 1 Middle East and Africa Market Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 2 Competitor Analysis (Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 3 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 4 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 5 Market Split by Application Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 6 Market Split by product Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 7 Market Split by End Users Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 8 Market Split by Distribution Channel Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Middle East and Africa API Intermediate market
Chapter 9 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Bulk Drug Intermediates have a significant impact on Middle East and Africa API Intermediate market? |
What are the key factors affecting the Bulk Drug Intermediates and Chemical Intermediates of Middle East and Africa API Intermediate Market? |
What is the CAGR/Growth Rate of Oncology during the forecast period? |
By type, which segment accounted for largest share of the Middle East and Africa API Intermediate Market? |
Which region is expected to dominate the Middle East and Africa API Intermediate Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Middle East and Africa API Intermediate Market
Request Sample